EFDID: 257846EFD: View Filing

Issuer: Verrica Pharmaceuticals Inc. (0001660334) - D

Accession: 0001660334-18-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001660334
  • Entity Name:
    Verrica Pharmaceuticals Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2013)
  • Address:
    200 Garrett Street
    Suite S
    Charlottesville, VA 22902
  • Persons:
    Related Persons 9
    Paul Manning
    Director, Promoter
    Sean Stalfort
    Director, Promoter
    Jayson Rieger
    Executive Officer, Director, Promoter
    Glenn Oclassen
    Director, Promoter
    Matthew Davidson
    Executive Officer, Director, Promoter
    Ted White
    Executive Officer
    Joseph Bonaccorso
    Executive Officer
    James C. Reebals
    Executive Officer, Promoter
    Anthony Cavallo
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/21/2018
  • First Sale Date:
    02/20/2018
  • Offering Amount:
    $21,000,000
  • Amount Sold:
    $19,999,995
  • Amount Remaining:
    $1,000,005
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MD, OH, VA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Verrica Pharmaceuticals Inc./James C. Reebals/James C. ReebalsCFO2018-02-21